semaglutide cardiovascular news today 🔴Cardiovascular outcomes with by severity of chronic kidney disease in type 2 diabetes: the FLOW trial⤵️ 🔹Semaglutide significantly reduced the risk of CV death/MI/stroke regardless of baseline CKD severity in participants Exploring Semaglutide's Cardiovascular Impact -

Tumour Biol 2014;35(1):247-256

Interestingly, our MS interactomic analysis also identifies TAMM41, an essential enzyme for the biosynthesis of cardiolipin 71 , as an active GLP-1R interactor

As for red flags, there arent a ton of them, but those who are pregnant or breast feeding are likely better off avoiding use, as theres just not enough information on safety, so always err on the side of caution

This matters because early fetal development begins before many people know they are pregnant

FDA-Approved Semaglutide & Tirzepatide Revolutionize Your Scale: Discover the Power of Weight Loss Injections Comprehensive Weight Management with Prescription at $49* Weight Loss Program Now Available in: Wisconsin, Illinois, Michigan, Indiana & Ohio Wegovy (Semaglutide GLP-1) $499 Now $199 Zepbound (Tirzepatide GLP-1/GIP) Available Most Affordable, Customized & Supervised Weight Loss Program No Hidden Fees | No Shipping Costs | Includes Intake, Follow-Up & Prescription Everyone's talking about targeted weight loss injections